Prosecution Insights
Last updated: October 25, 2026

Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi currently manages 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are distributed across 2 distinct examiners and various art units, indicating a spread of intellectual property across different regulatory silos. This distribution suggests that the company is navigating multiple examination paths simultaneously within the patent office. Each pending action is handled by a unique examiner, which may lead to varying prosecution timelines across the various units.

Natalie Nicole Thomas is identified as the busiest examiner for this portfolio. She is responsible for 1 pending office action, which is part of the total 2 pending actions for the company. This concentration suggests that while the portfolio is small, individual examiner interactions are significant for prosecution progress. Practitioners should monitor the specific requirements of Natalie Nicole Thomas as her workload constitutes a significant portion of the current activity. The outcome of this specific case will have a direct impact on the overall success rate of the company's applications.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
2
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (50%)
1
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (50%)
Multi-statute (no §101)1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
50% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
THOMAS, NATALIE NICOLE 1 0.0% +0.0%
KRISHNAN, GANAPATHY 1 52.7% +1.3%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18725141 CARTRIDGE INJECTOR SYSTEM WITH IMPROVED LENS BENDING FEATURES FOR USE IN LENS IMPLANTATION THOMAS, NATALIE NICOLE —
18702951 OPHTHALMIC FORMULATIONS FOR TREATMENT OF PRESBYOPIA, DRY EYE DISEASE AND COMPUTER VISION SYNDROME KRISHNAN, GANAPATHY —

Top Art Units

Art UnitApps
3774 1
1693 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18725141 CARTRIDGE INJECTOR SYSTEM WITH IMPROVED LENS BENDING FEATURES FOR USE IN LENS IMPLANTATION THOMAS, NATALIE NICOLE 3774 §103 Non-Final OA — Pending Jun 28, 2024
18702951 OPHTHALMIC FORMULATIONS FOR TREATMENT OF PRESBYOPIA, DRY EYE DISEASE AND COMPUTER VISION SYNDROME KRISHNAN, GANAPATHY 1693 §103§112 Non-Final OA — Pending Apr 19, 2024

Managing Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi have?

Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi applications?

Natalie Nicole Thomas has the most, with 1 of Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi's pending office actions.

What technology area are Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi's patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month